Becton Dickinson & Co is a global medical technology company dedicated to advancing healthcare by providing innovative solutions in medical devices, instrument systems, and reagents. The company's mission is to enhance the safety and efficiency of healthcare delivery, focusing on improving patient outcomes and streamlining clinical workflows. Becton Dickinson's strategy involves leveraging cutting-edge technology and extensive research to develop products that address critical healthcare challenges, while maintaining a commitment to sustainability and corporate responsibility. Through its diverse portfolio, Becton Dickinson operates in various segments, including medication management, diagnostics, and biosciences, serving healthcare providers and patients worldwide.

BECTON DICKINSON & CO

Becton, Dickinson and Company (BD) continues to solidify its position as a major player in the diagnostics landscape, thanks in part to its strategic innovations and investments in emerging markets. Recognized for its contributions to infectious disease diagnostics, BD launched the BD COR MX/PX System in May 2022. This system...

Becton, Dickinson and Company Positioned as a Leading Innovator in Infectious Disease Diagnostics and Over-the-Counter Test Markets Amid Rapid Growth